Home > Posts > Dr. Mark Nogueira

Dr. Mark Nogueira

Dr. Mark Nogueira
Mark A. Nogueira, MD is a specialist in minimally invasive urologic procedures. Dr. Nogueira was part of one of the first teams of doctors to perform and develop robotic radical cystectomy for bladder cancer. He has extensive experience with minimally invasive techniques for prostate, kidney and bladder cancer. He is also a specialist in minimally invasive therapies for the treatment of benign prostatic hyperplasia. Dr. Nogueira has published several articles and textbook chapters regarding robotic and laparoscopic surgery in major medical journals. He has also presented his research to other doctors at many national and international meetings. Dr. Nogueira received his medical degree from the Mount Sinai School of Medicine and completed surgery and urology training at the University of Buffalo. He completed a fellowship in minimally invasive Urologic Oncology at the Roswell Park Cancer Institute.

Languages Spoken:

English

Medical School:

Mount Sinai School of Medicine

Residency:

State University of New York at Buffalo

Undergraduate:

Cornell University

Locations

Optum Urology Mount Kisco, New York

100 South Beford RoadMount Kisco, New York, 10549United States
914-242-1520 | Visit Website

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only